AbbVie's CANASA label update and ABBV-253 trial recruitment lead busy week of registry changesOct 16Weekly roundup, 9 itemsABBV-1042ABBV-253Updated
FDA approves three generic drug applications, four submissions, across Amneal and ANI PharmsOct 15Weekly roundup, 3 itemsAmneal Pharmaceuticals, LLCAni Pharmaceuticals Inc
Takeda gets two mesalamine label approvals; psoriatic arthritis trial still not recruitingOct 14Weekly roundup, 3 itemsmesalamineTakeda Pharmaceutical Co LtdUpdated
Sign inSign in